Long-term outcomes and predictors of vedolizumab persistence in ulcerative colitis

Abstract

VDZ effectiveness appears enduring with favourable long-term safety profile. VDZ persistence was influenced by previous exposure to biologics/small molecules, disease distribution and steroid use at baseline in our study.